Frage 1
Frage
Multiple Sclerosis is a condition whereby the [blank_start]myelin sheathes[blank_end] of [blank_start]CNS tracts[blank_end] are broken down. Lesions also appear in the [blank_start]CNS[blank_end], and these are referred to as [blank_start]plaques[blank_end].
Antworten
-
myelin sheathes
-
axons
-
cell bodies
-
dendrites
-
CNS tracts
-
PNS neurons
-
plaques
-
cysts
-
aggregates
-
CNS
-
PNS
Frage 2
Frage
Multiple Sclerosis affects [blank_start]only CNS tracts[blank_end]
Frage 3
Frage
Multiple Sclerosis is more prevalent in ...
Frage 4
Frage
Multiple Sclerosis tends to initially present ...
Frage 5
Frage
To be specific, Multiple Sclerosis is the loss of the cells that produce myelin in the CNS, known as [blank_start]oligodendrocytes[blank_end]
Frage 6
Frage
Multiple Sclerosis tends to cause pyramidal dysfunction. This can cause such things as spasticity, weakness and increased tone. What is the main tract of the pyramidal tract group?
[blank_start]Corticospinal tract[blank_end]
Frage 7
Frage
The pyramidal dysfunction associated with Multiple Sclerosis tends to cause spasticity/weakness/etc to the [blank_start]extensors[blank_end] of the upper limbs and the [blank_start]flexors[blank_end] of the lower limbs
Antworten
-
extensors
-
flexors
-
flexors
-
extensors
Frage 8
Frage
Which visual condition is present in 50% of MS sufferers, and is the first sign of MS in 20% of sufferers?
[blank_start]Optic neuritis[blank_end]
Frage 9
Frage
How does Optic Neuritis present? (2 right answers)
Antworten
-
Acute onset pain in eye upon eye movement
-
Central blurriness/visual loss
-
Peripheral blurriness/visual loss
-
Red eye
-
Floaters in visual field
Frage 10
Frage
In most cases, optic neuritis is a self-resolving condition given a few months.
Frage 11
Frage
Some multiple sclerosis patients describe an intense pain of the face that can be triggered simply by light touch of the face. This condition is typically caused by impingement of one of the cranial nerves by a blood vessel, and is called [blank_start]Trigeminal Neuralgia[blank_end].
Frage 12
Frage
Trigeminal Neuralgia only tends to affect 2-4% of MS patients. These patients are typically treated using an anticonvulsant called
Antworten
-
Sodium Valproate
-
Carbamazepine
-
Lamotrigine
-
Acetazolamide
-
Diazepam
Frage 13
Frage
What are the main two cerebellar manifestations of Multiple Sclerosis?
Antworten
-
Ataxia
-
Tremor
-
Slurred speech
-
Dizziness
-
Headaches
Frage 14
Frage
Multiple Sclerosis can cause CNVI palsy. How would this present?
Antworten
-
Inability to abduct the eyes, causing diplopia
-
Inability to gaze downwards, causing diplopia
-
Negative pupillary light reflex
Frage 15
Frage
In addition to this, Multiple Sclerosis can also cause difficulty in adduction of the eyes. This occurs when a plaque forms in the Medial Longitudinal Fasciculus and presents as Nystagmus of the [blank_start]abducting[blank_end] eye and is called [blank_start]Internuclear Ophthalmoplegia[blank_end]
Frage 16
Frage
70-80% of Multiple Sclerosis sufferers have lower urinary tract problems. The most common are [blank_start]increased[blank_end] frequency and [blank_start]urge[blank_end] incontinence.
Antworten
-
increased
-
decreased
-
urge
-
stress
-
overflow
Frage 17
Frage
Amantadine is a drug commonly prescribed to Multiple Sclerosis patients suffering from
Frage 18
Frage
For a diagnosis of Multiple Sclerosis to be confirmed, the patient must have suffered at least 2 episodes suggestive of demyelination.
Frage 19
Frage
Name the criteria typically used to diagnose multiple sclerosis.
The [blank_start]McDonald[blank_end] Criteria
Frage 20
Frage
Which imaging study should be conducted in order to diagnose Multiple Sclerosis?
Frage 21
Frage
Multiple Sclerosis may also be diagnosed by means of lumbar puncture to look for inflammation in the CNS. The CSF is tested for oligoclonal bands of [blank_start]IgG[blank_end] on electrophoresis, which are inflammation markers found in 75–85% of people with Multiple Sclerosis.
Frage 22
Frage
In the most basic sense, acute exacerbations of multiple sclerosis are treated by the following:
Mild: [blank_start]Symptomatic treatment[blank_end]
Moderate: [blank_start]Oral steroids[blank_end]
Severe: Admit & give [blank_start]IV Steroids[blank_end]
Antworten
-
Symptomatic treatment
-
Watchful waiting
-
No treatment
-
Oral steroids
-
Oral anticonvulsants
-
Oral antidepressants
-
IV Steroids
-
IV Anticonvulsants
-
IV Antiepileptics
Frage 23
Frage
Baclofen is a medication used to treat ... in MS patients
Frage 24
Frage
Sensory symptoms caused by MS (pain, paraesthesia, numbness, etc) can be treated by the following:
Anti convulsant, e.g. [blank_start]Gabapentin[blank_end]
Anti depressant, e.g. [blank_start]Amitriptyline[blank_end]
Antworten
-
Gabapentin
-
Amitriptyline
-
Amantadine
Frage 25
Frage
The lower urinary tract dysfunction caused by multiple sclerosis can be treated by a Vasopressin Analogue called ...
Antworten
-
Desmopressin
-
Terlipressin
-
Carbopressin
Frage 26
Frage
Despite this, the most common long term management of lower urinary tract dysfunction in multiple sclerosis patients is...
Frage 27
Frage
If an individual is thought to be at risk of developing MS or has two relapses of the condition, disease modifying therapy can be prescribed.
Match each first line therapy to it's description.
[blank_start]Interferon Beta[blank_end]: Balances expression of pro- and anti-inflammatory agents in the brain & reduces number of inflammatory cells crossing the blood brain barrier.
[blank_start]Glitiramer Acetate[blank_end]: Shifts the population of T cells from pro-inflammatory Th1 T-cells to regulatory Th2 T-cells that suppress the inflammatory response.
Antworten
-
Interferon Beta
-
Glitiramer Acetate
-
Interferon Gamma
Frage 28
Frage
How are Interferon Beta & Glitiramer Acetate (Copaxone) administered in MS patients?
Frage 29
Frage
In patients with highly active multiple sclerosis, whereby interferon beta and Copaxone are ineffective, what is the second line disease modifying agent that should be given?
Frage 30
Frage
Second line treatment can also come in the rather expensive form of monoclonal antibodies. Drugs such as Natalizumab are able to reduce the ability of inflammatory immune cells to attach to and pass through the cell layers lining the
Antworten
-
Blood-brain barrier
-
White matter tracts of the brain (e.g. internal capsule)
-
Grey matter areas of the brain affected by MS such as the basal ganglia
-
myelin sheathes of CNS tracts
Frage 31
Frage
The presence of which Human Leukocyte Antigen predisposes to multiple sclerosis?
Antworten
-
HLA B27
-
HLA DR2
-
HLA D45
-
HLA BR7
Frage 32
Frage
Which type of multiple sclerosis is the most common?
Antworten
-
Relapsing Remitting
-
Primary Progressive
-
Secondary Progressive
-
Progressive Relapsing
Frage 33
Frage
Match the MS types to its definition:
[blank_start]Relapsing Remitting MS[blank_end] = Bouts of disease which occur months/years apart. Between these bouts there is no worsening in the patient's disability.
[blank_start]Secondary Progressive MS[blank_end] = Starts like relapsing remitting however then becomes a linear, constant attack on the myelin.
[blank_start]Primary Progressive MS[blank_end] = A constant attack on the myelin of the CNS - no bouts, just a constant disease state.
[blank_start]Progressive Relapsing[blank_end] = Bouts of disease which occur months/years apart. Between these bouts there is a progressive worsening of the condition.
Antworten
-
Progressive Relapsing
-
Primary Progressive MS
-
Secondary Progressive MS
-
Relapsing Remitting MS
Frage 34
Frage
Charcot's triad is indicative of Multiple Sclerosis. This consists of ...
Antworten
-
Dysarthria
-
Nystagmus
-
Intention Tremor
-
Chorea
-
Myoclonus
-
Lhermitte's Sign
-
Incontinence
Frage 35
Frage
[blank_start]Lhermitte's[blank_end] sign = Electric shock-like jerk which potentiates down the spine and radiates into the limbs when an individual bends their neck forwards.
Frage 36
Frage
Baclofen is a muscle relaxant used to treat [blank_start]muscle spasticity[blank_end]
Antworten
-
muscle spasticity
-
intention tremor
-
incontinence
-
dysarthria